en · de · es · fr · pt
glossary-desk.peptides6155.com › Guide › Tb-500 Identity And Chemical Background — Worked Examples

Tb-500 Identity And Chemical Background — Worked Examples

By Editorial Desk · published 2025-08-13 · last reviewed 2025-09-20 · Guide

This is a working overview of heptapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2025-09-20 and is reviewed periodically as new material appears.

TB-500 Identity and Chemical Background

TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.

Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.

Identification and Molecular Background

TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.

Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.

Tb-500 at a glance

PropertyValueNotes
Physical formLyophilised powderSealed vial; reconstituted before laboratory use
AppearanceWhite to off-white solidVisual descriptor used on certificates of analysis
Solubility classWater-solubleDissolves in water and aqueous buffers
Reported mass, fragmentNear 889 DaValue depends on the stated sequence
Reported mass, parent proteinNear 4963 Da43-residue thymosin beta-4

Identity And Naming Background

Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.

Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.

Related pages on this site

Identity and Reported Background

Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.

Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.

TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.

Background from the literature

=== Return to the Republic === Shortly after the end of the Provisional Government, in 1910, formal relations between Cuba and Spain were resumed. In October 1912, the Grand Commander of the Supreme Council, Manuel S. Castellanos, and the Freemason Luther S. Harvey, travelled to Washington, D.C., to attend the International Conference of Supreme Councils. During the runup to the 1912 Cuban general election, the Lodges of Cuba were once again subjected to internal divisions motivated by the political reality. That year, José Fernández Pellón Castellanos and the Jurisprudence Commission released a statement which the Grand Lodge, and Freemasonry, specifically forbade the practice of politics in the Lodge. At the same time, Grand Master Francisco Sánchez Curbelo was in the election to become a representative in the Cuban House of Representatives, and in an issue of La Gran Logia, Aurelio Miranda tacitly expressed his desire that Freemasons should vote for him. At the quarterly meeting of the High Chamber of the Grand Lodge of Cuba, the President of the High Chamber, Valdés Codina presided over a proposal: "To recommend to all the lodges of the obedience, so that they in turn may recommend to the members of all their columns, the supreme convenience of each one casting his vote for the masons who are nominated, whatever the party or group that nominates him." In a public response to the calls to elect Grand Master Francisco Sánchez Curbelo, he replied: "...It is necessary to Respect everyone, listen to everyone,...

== Side effects == There are some reports of mild pain or skin irritation after red-light therapy. The long-term effects on the skin or the hair are not known. Eye protection is suggested for some devices. For skin applications, different wavelengths of light may result in different biological effects depending on the person's skin type, race, and ethnicity. Clinical guidelines suggest that a dermatologist be consulted before undergoing treatment. For safety, use should be limited to a device approved for human use by the relevant government authority; for example, in the US, it is suggested that only devices certified by the FDA for dermatologic application be used.

=== Adhesive consolidation === Fragile and brittle fabrics, or those that would be damaged by needle and thread repairs, can be consolidated using adhesive techniques. Consolidation is less common than stitching methods. Lack of extensive research into the long-term stability of synthetic adhesives and their compatibility with natural fibers has contributed to polarized debate over the appropriateness of adhesive consolidation. The complexity of treatments and limited expertise with theory and practice and often prevent conservators from choosing this option. Among the variables to be considered are the concentration and number of coats of adhesive, substrates, and application and reactivation methods. Evaluation of past consolidation failures and successes, and interdisciplinary collaboration among professionals, have led to a more refined and informed practice. Despite the challenges, skillfully applied adhesive supports are a viable alternative to stitching.

Sources: en.wikipedia.org

Reference notes

Sternglass, a radiologist at the University of Pittsburgh, published several studies describing the effect of radiation from nuclear tests and the vicinity of nuclear power plants on infant mortality. In 1971, the UASEC reduced the maximum allowable radiation dose by a factor of 100. Subsequently, nuclear technology was based on the principle of "As Low As Reasonably Achievable" (ALARA). This was a coherent principle as long as it was assumed that there was no threshold and that all doses were additive. In the meantime, a transition to "As High As Reasonably Safe" (AHARS) is increasingly being discussed. For the question of evacuation after accidents, a transition to AHARS seems absolutely necessary. In both the Chernobyl and Fukushima cases, hasty, poorly organized and poorly communicated evacuations caused psychological and physical damage to those affected - including documented deaths in the case of Fukushima. By some estimates, this damage is greater than would have been expected had the evacuation not taken place. Voices such as Geraldine Thomas therefore question such evacuations in principle and call for a transition to shelter-in-place wherever possible.

==== Protease-specific Arrays ==== A protease specific protein array based on immobilized antibodies designed to capture specific proteases from biological samples offers a step up in analysis of protein levels beyond transcript expression. Capture antibodies spotted to nitrocellulose membranes can bind proteases in complex mixtures which have been pre-incubated and bound by detection antibodies allowing for parallel analysis of relative protease levels. These arrays offer parallelization of protein levels over traditional western blot. Unfortunately, these assays fail to provide insight on enzymatic function for proteases and suffer similar drawbacks to western blots regarding reliable quantification.

=== Italy === Since the Fleischmann and Pons announcement, the Italian national agency for new technologies, energy and sustainable economic development (ENEA) has funded Franco Scaramuzzi's research into whether excess heat can be measured from metals loaded with deuterium gas. Such research is distributed across ENEA departments, CNR laboratories, INFN, universities, and industrial laboratories in Italy, where the group continues to try to achieve reliable reproducibility (i.e. getting the phenomenon to happen in every cell, and inside a certain frame of time). In 2006–2007, the ENEA started a research program which claimed to have found excess power of up to 500 percent, and in 2009, ENEA hosted the 15th cold fusion conference.

=== Physical === Physical deterioration of waterlogged wood can happen immediately through the evaporation of the water. If this happens rapidly, the cells in the wood can shrink and collapse. This damage might be inevitable depending on accessibility to treatment. Additionally waterlogged wood should never be handled extensively or put on exhibit for long periods of time. Most waterlogged wood is such that decayed wood cells in the material fill with water. Depending on the wood type and how long the wood has been in water, removal of the water from the cells too rapidly (in the form of natural drying or other) could apply major stress to the cell walls and cause them to collapse. Improperly dried waterlogged irreversibly shrinks, warps, cracks and there is risk of loss to the original surface.

Sources: en.wikipedia.org

Notes from published material

== Bibliography == Borgelt LM, O'Connell MB, Smith JA, Calis KA (2010). Women's Health Across the Lifespan: A Pharmacotherapeutic Approach. ASHP. pp. 513–. ISBN 978-1-58528-194-7. Greenberger NJ, Blumberg R, Burakoff R, eds. (23 April 2009). Current Diagnosis and Treatment in Gastroenterology, Hepatology, and Endoscopy. McGraw Hill Professional. pp. 282–. ISBN 978-0-07-149007-8. South-Paul JE, Matheny SC, Lewis EL (4 September 2007). Current Diagnosis & Treatment in Family Medicine (Second ed.). McGraw-Hill Companies. ISBN 978-0-07-146153-5. Potts JM, ed. (2008). Genitourinary Pain and Inflammation: Diagnosis and Management. Springer. pp. 121–. ISBN 978-1-58829-816-4. Zderic S, Kirk J (15 September 2008). Pediatric Urology for the Primary Care Provider. Thoroughfare, NJ: SLACK Incorporated. pp. 22–. ISBN 978-1-55642-785-5.

Carbamazepine and its bio-transformation products have been detected in wastewater treatment plant effluent and in streams receiving treated wastewater. Field and laboratory studies have been conducted to understand the accumulation of carbamazepine in food plants grown in soil treated with sludge, which vary with respect to the concentrations of carbamazepine present in sludge and in the concentrations of sludge in the soil. Taking into account only studies that used concentrations commonly found in the environment, a 2014 review concluded that "the accumulation of carbamazepine into plants grown in soil amended with biosolids poses a de minimis risk to human health according to the approach."

This drastically revamped King Crimson had no plans to record in the studio, focusing instead on playing "reconfigured" versions of past material live. According to Levin, the band "were instructed/advised by Robert Fripp to look at the older classic King Crimson material as if we had written it. And so we did that with a lot of older material that the band had done before the '80s. We didn't actually cover that much of the '80s material outside of a few songs." For the most part, this approach would remain consistent for the remainder of the band's lifetime. In early 2014, the band's repertoire included songs from the run of albums between In the Court of the Crimson King and Larks' Tongues in Aspic for the first time since 1974, as well as reviving song material from Red. No songs with vocals by Belew were included in the setlist, although some instrumentals from his tenure were played. Some material from A Scarcity of Miracles was also incorporated into the band's repertoire. After rehearsing in England, King Crimson toured North America from 9 September to 6 October. Recordings from the Los Angeles dates were released as Live at the Orpheum; this included the newly-written instrumentals "Banshee Legs Bell Hassle" and "Walk On: Monk Morph Chamber Music". Tours of Europe, Canada, and Japan followed in the later half of 2015. Brand-new songs mainly written by Fripp and Jakszyk were debuted at the concerts, as well as drum showcases.

Sources: en.wikipedia.org

Frequently asked questions

Is TB-500 the same as thymosin beta-4?

No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.

Why do product listings show different sequences?

Naming for research peptides is not standardised, and suppliers sometimes apply the same label to different chain lengths. Certificates of analysis and mass data are the practical way to determine what a given lot contains.

What is the reported molecular mass?

The fragment commonly cited under this label is reported near 889 Da, and the parent protein near 4963 Da. Reported values shift with the exact sequence and with residual counter-ions or water in the sample.

What is TB-500 chemically?

It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.

Network